US2003091550A1PendingUtilityA1
Novel strains of bacillus thuringiensis and pesticidal composition comprising them
Est. expiryOct 27, 2015(expired)· nominal 20-yr term from priority
C12R 2001/075C07K 2319/00C12N 1/205C07K 14/325
39
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates particularly to a strain of Bacillus thuringiensis characterized in that it expresses the gene sigma E (σE) and does not sporulate at all or little sporulates or does not produce any viable spores. The invention also relates to a pesticide composition containing said strain of Bacillus thuringiensis.
Claims
exact text as granted — not AI-modified1 ) Bacillus thuringiensis characterized in that it expresses the sigma E (θE) gene and does not sporulate or sporulates little or does not produce viable spores.
2 ) Bacillus thuringiensis according to claim 1 , characterized in that the strain does not sporulate.
3 ) Bacillus thuringiensis according to one of claims 1 and 2 , characterized in that it is a strain not expressing the sigma K gene.
4 ) Bacillus thuringiensis according to claim 3 , characterized in that the SigK gene has been interrupted by introduction of a DNA sequence or has been at least partially deleted.
5 ) Bacillus thuringiensis according to claim 4 , characterized in that the sigK gene has been interrupted by introduction of a DNA sequence conferring a positive selection character on the strain.
6 ) Bacillus thuringiensis according to claim 5 , characterized in that the positive selection character is resistance to an antibiotic.
7 ) Bacillus thuringiensis according to one of claims 1 to 6 , characterized in that the Bt strain expresses one or more Cry genes.
8 ) Bacillus thuringiensis, according to claim 7 , characterized in that the Cry gene(s) is/are carried by a vector, for example a plasmid.
9 ) Bacillus thuringiensis according to claim 7 , characterized in that the Cry genes are integrated into the chromosome.
10 ) Bacillus thuringiensis according to one of claims 1 to 9 , characterized in that it expresses a protein of interest carried by a self-replicating plasmid or by a DNA sequence integrated into the chromosome.
11 ) Bacillus thuringiensis according to claim 10 , characterized in that it contains a DNA sequence in the SigK gene expressing a protein of interest.
12 ) Bacillus thuringiensis according to claim 10 , characterized in that it contains in replacement of all or part of the SigK gene a DNA sequence expressing a protein of interest.
13 ) Bacillus thuringiensis 407 SigK − (pHT410) deposited at the National Collection of Microorganism Cultures of the Institut Pasteur on Oct. 26, 1995 under the number I-1634.
14 ) Bacillus thuringiensis Kto SigK − (pHTF3-1C/A(b)-IRS-T-Δ) deposited at the National Collection of Microorganism Cultures of the Institut Pasteur on Oct. 22, 1996 under the number I-1776.
15 ) Pesticidal composition, characterized in that it contains a Bt strain according to one of claims 1 to 14 .
16 ) Composition according to claim 15 , characterized in that the Bt strain has been inactivated.
17 ) Composition according to one of claims 15 and 16 , characterized in that it has been inactivated by physical means.
18 ) Composition according to one of claims 15 and 16 , characterized in that it has been inactivated by irradiation.
19 ) Composition according to one of claims 15 and 16 , characterized in that it has been inactivated by chemical means.
20 ) Composition according to one of claims 15 to 19 , characterized in that the Bt strain has been treated to improve the digestibility of the strain or alternatively to improve the accessibility of the protein.
21 ) Composition according to claim 20 , characterized in that the Bt strain has been treated by sonication.
22 ) Nucleotide sequence containing the SigE gene, not containing any active SigK gene and containing a sequence coding for a gene of interest.Join the waitlist — get patent alerts
Track US2003091550A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.